TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces Osteoclast differentiation

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Yen, Men Luh ^a,b   Hsu, Ping Ning ^a,b   Liao, Hsiu Jung ^a   Lee, Be Hang ^a   Tsai, Hwei Fang ^c,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE DERIVATIVE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL LINE; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; HUMANS; MICE; OSTEOCLASTS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITINATION;

EID: 84862263981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038048     Document Type: Article

References (36)

1. Walsh MC, Choi Y, (2003) Biology of the TRANCE axis. Cytokine Growth Factor Rev 14: 251 263.
2. Boyle WJ, Simonet WS, Lacey DL, (2003) Osteoclast differentiation and activation. Nature 423: 337 342.
3. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165 176.
4. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315 323.
5. Asagiri M, Takayanagi H, (2007) The molecular understanding of osteoclast differentiation. Bone 40: 251 264.
6. Clowes JA, Riggs BL, Khosla S, (2005) The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208: 207 227.
7. Walsh NC, Crotti TN, Goldring SR, Gravallese EM, (2005) Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208: 228 251.
8. Kim N, Kadono Y, Takami M, Lee J, Lee SH, (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202: 589 595.
9. Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, (2005) M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115: 3418 3427.
10. Takayanagi H, (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 83: 170 179.
11. Cheng X, Kinosaki M, Murali R, Greene MI, (2003) The TNF receptor superfamily: role in immune inflammation and bone formation. Immunol Res 27: 287 294.
12. Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, (2004) Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death Differ 11: S97 107.
13. Park H, Jung YK, Park OJ, Lee YJ, Choi JY, (2005) Interaction of fas ligand and fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol 175: 7193 7201.
14. Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, (2008) TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells. Mol Immunol 45: 2205 2213.
15. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673 682.
16. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13: 1015 1024.
17. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4: 353 362.
18. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4: 1041 1049.
19. Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, (2001) Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. Embo J 20: 1271 1280.
20. Bai S, Zha J, Zhao H, Ross FP, Teitelbaum SL, (2008) Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts. J Biol Chem 283: 30861 30867.
21. Massey HM, Flanagan AM, (1999) Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106: 167 170.
22. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stroma cells. Proc Natl Acad Sci U SA 87: 7260 7264.
23. Chou AH, Tsai HF, Wu YY, Hu CY, Hwang LH, (2005) Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J Immunol 174: 2160 2166.
24. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418: 443 447.
25. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273: 14363 14367.
26. Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M, (2000) Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kB ligand (RANKL). J Biol Chem 275: 31155 31161.
27. Li X, Udagawa N, Takami M, Sato N, Kobayashi Y, (2003) p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 144: 4999 5005.
28. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, (2002) U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277: 47366 47372.
29. Negishi-Koga T, Takayanagi H, (2009) Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev 231: 241 256.
30. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889 901.
31. Takayanagi H, (2007) The role of NFAT in osteoclast formation. Ann N Y Acad Sci 1116: 227 237.
32. Lamothe B, Campos AD, Webster WK, Gopinathan A, Hur L, (2008) The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J Biol Chem 283: 24871 24880.
33. Jin W, Chang M, Paul EM, Babu G, Lee AJ, (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 118: 1858 1866.
34. Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, (2007) TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun 359: 1044 1049.
35. Walsh MC, Kim GK, Maurizio PL, Molnar EE, Choi Y, (2008) TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL. PLoS One 3: e4064.
36. Deng L, Wang C, Spencer E, Yang L, Braun A, (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351 361.